Menu
Recruiting NCT02266615

Biobank Clinical Genetics Maastricht (KG01)

Observational Genetic Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Biobanking of biomaterial for future genetic research..
Who it may be relevant to
Registry conditions: Genetic Disease. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Biobank Clinical Genetics Maastricht

Overview

Collection of coded biomaterial and clinical data with patients consent for future research.

Detailed description

Collection of coded biomaterial and clinical data with patients consent for future research, with the purpose to indentify new gene mutation and prossibilities for treatment in the future.

Interventions

  • Genetic Biobanking of biomaterial for future genetic research.

Primary outcome measures

  • Comparing genes to discover unknown functions [Time frame: Genes will be sequenced and compared, within an expected average of 6 months.]

Eligibility criteria

Inclusion criteria

  • New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital
  • Withdrawal of body material for genetic diagnostics.

Exclusion criteria

  • Patient does not understand the Dutch language.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Netherlands · 1 center
  • Maastricht University Medical Center — Maastricht

Identifiers

NCT: NCT02266615 · METC-14-4-077

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗